Table 5.
Multi-drug resistance pattern of UTIs causing bacterial isolates
| Gram-reaction | Bacterial isolate | Total (n (%)) | R1 | R2 | R3 | R4 | ≥ R5 | MDR (n (%)) |
|---|---|---|---|---|---|---|---|---|
| Gram-negative (24/85%) | E. coli | 16 (57) | 1 (6.3 ) | 3(18.8 ) | 4 (25 ) | 2 (12.5 ) | 4 (25) | 13 (81.3) |
| K. pneumonia | 4 (14) | 0 (0) | 0(0) | 1 (25 ) | 1 (25 ) | 1 ( 25) | 3 (75) | |
| E. aerogenes | 2 (7) | 0 (0) | 1 (50) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | |
| P. mirabilis | 2 (7) | 0 (0) | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | |
| Gram positive (4/15%) | S. aureus | 3 (11) | 0(0) | 0 (0) | 3 (100) | 0 (0) | 0 (0) | 3 (100) |
| CONS | 1 (4) | 0(0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 1 (100) | |
| Total | 28 (100) | 1(3.6) | 5 (17.9) | 8 (28.6) | 4 (14.3) | 5 (17.9) | 22 (78.6) |
R1; resistance to one group of a drug; R2; resistance to two groups of a drug; R3; resistance to three groups of a drug; R4; resistance to four groups of a drug; R5; resistance to five or more drug; MDR; Multidrug resistance; CONS; coagulase-negative staphylococcus.